These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7202473)

  • 1. Simultaneous determination of the intravenous and oral pharmacokinetic parameters of D,L-verapamil using stable isotope-labelled verapamil.
    Eichelbaum M; Somogyi A; von Unruh GE; Dengler HJ
    Eur J Clin Pharmacol; 1981 Jan; 19(2):133-7. PubMed ID: 7202473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superiority of stable isotope techniques in the assessment of the bioavailability of drugs undergoing extensive first pass elimination. Studies of the relative bioavailability of verapamil tablets.
    Eichelbaum M; Dengler HJ; Somogyi A; von Unruh GE
    Eur J Clin Pharmacol; 1981 Jan; 19(2):127-31. PubMed ID: 7202472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin.
    Fromm MF; Busse D; Kroemer HK; Eichelbaum M
    Hepatology; 1996 Oct; 24(4):796-801. PubMed ID: 8855178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological disposition of verapamil in man.
    Schomerus M; Spiegelhalder B; Stieren B; Eichelbaum M
    Cardiovasc Res; 1976 Sep; 10(5):605-12. PubMed ID: 971476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective first-pass metabolism of highly cleared drugs: studies of the bioavailability of L- and D-verapamil examined with a stable isotope technique.
    Vogelgesang B; Echizen H; Schmidt E; Eichelbaum M
    Br J Clin Pharmacol; 1984 Nov; 18(5):733-40. PubMed ID: 6508982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, bioavailability and ECG response of verapamil in patients with liver cirrhosis.
    Somogyi A; Albrecht M; Kliems G; Schäfer K; Eichelbaum M
    Br J Clin Pharmacol; 1981 Jul; 12(1):51-60. PubMed ID: 7248141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of pharmacokinetic profiles of verapamil and drug-drug interactions induced by a CYP inhibitor using a stable isotope-labeled compound.
    Kataoka M; Kojima C; Ueda K; Minami K; Higashino H; Sakuma S; Togashi K; Mutaguchi K; Yamashita S
    Drug Metab Pharmacokinet; 2016 Dec; 31(6):405-410. PubMed ID: 27876352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic interaction between verapamil and metoprolol in the dog. Stereochemical aspects.
    Murthy SS; Nelson WL; Shen DD; Power JM; Cahill CM; McLean AJ
    Drug Metab Dispos; 1991; 19(6):1093-100. PubMed ID: 1687016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium antagonists. Pharmacokinetic properties.
    Kates RE
    Drugs; 1983 Feb; 25(2):113-24. PubMed ID: 6339196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of verapamil in patients with atrial fibrillation.
    Anderson P; BondessoN U; Sylvén C
    Eur J Clin Pharmacol; 1982; 23(1):49-57. PubMed ID: 7128672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verapamil disposition and effect on PQ-intervals after buccal, oral and intravenous administration.
    Asthana OP; Woodcock BG; Wenchel M; Frömming KH; Schwabe L; Rietbrock N
    Arzneimittelforschung; 1984; 34(4):498-502. PubMed ID: 6540109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verapamil disposition kinetics in chronic atrial fibrillation.
    Kates RE; Keefe DL; Schwartz J; Harapat S; Kirsten EB; Harrison DC
    Clin Pharmacol Ther; 1981 Jul; 30(1):44-51. PubMed ID: 7237897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of the absolute bioavailability of flecainide using stable isotope technique.
    Hage K; Bühl K; Fischer C; Knebel NG
    Eur J Clin Pharmacol; 1995; 48(1):51-5. PubMed ID: 7621848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of prolonged submaximal exercise on the pharmacokinetics of verapamil in humans.
    Mooy J; Arends B; van Kemenade J; Boehm R; Rahn KH; van Baak M
    J Cardiovasc Pharmacol; 1986; 8(5):940-2. PubMed ID: 2429094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of verapamil.
    Hamann SR; Blouin RA; McAllister RG
    Clin Pharmacokinet; 1984; 9(1):26-41. PubMed ID: 6362951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of verapamil, nifedipine and diltiazem.
    Echizen H; Eichelbaum M
    Clin Pharmacokinet; 1986; 11(6):425-49. PubMed ID: 3542336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single dose pharmacokinetics and bioavailability of methadone in man studied with a stable isotope method.
    Meresaar U; Nilsson MI; Holmstrand J; Anggård E
    Eur J Clin Pharmacol; 1981; 20(6):473-8. PubMed ID: 7286059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of bioavailability of experimental single-unit sustained release tablets of verapamil hydrochloride using the stable isotope technique.
    Marvola M; Kannikoski A; Taskinen J; Ottoila P
    J Pharm Pharmacol; 1985 Nov; 37(11):766-70. PubMed ID: 2867156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of cimetidine on verapamil kinetics and dynamics.
    Smith MS; Benyunes MC; Bjornsson TD; Shand DG; Pritchett EL
    Clin Pharmacol Ther; 1984 Oct; 36(4):551-4. PubMed ID: 6478741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.